161 related articles for article (PubMed ID: 6441709)
21. [Evolution of bacterial resistance to five aminoglycosides. A study of 3,354 strains isolated in a hospital milieu].
Fourche J; Texier-Maugein J; Mormede M
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):665-70. PubMed ID: 3054744
[TBL] [Abstract][Full Text] [Related]
22. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Jones RN; Barry AL; Thornsberry C
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
Phillips I; King A; Shannon K
Am J Med; 1986 Jun; 80(6B):48-55. PubMed ID: 3728534
[TBL] [Abstract][Full Text] [Related]
25. Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.
Woolfrey BF; Fox JM; Quall CO; Lally RT
Antimicrob Agents Chemother; 1983 Nov; 24(5):764-70. PubMed ID: 6419674
[TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
27. In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.
Duncan IB; Skulnick M; Marshall PW
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():1-6. PubMed ID: 6438046
[TBL] [Abstract][Full Text] [Related]
28. Invitro comparative evaluation of aminoglycosides at a cancer centre.
Biswas SK; Kelkar RS
Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests.
Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
Eur J Clin Microbiol; 1986 Feb; 5(1):18-22. PubMed ID: 2938944
[TBL] [Abstract][Full Text] [Related]
30. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
31. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
Digranes A; Dibb WL; Benonisen E; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
[TBL] [Abstract][Full Text] [Related]
32. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
Moellering RC; Wennersten C; Kunz LJ; Poitras JW
Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
Ismaeel NA
Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
[TBL] [Abstract][Full Text] [Related]
34. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
Juhlin I; Tunevall G
Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
[TBL] [Abstract][Full Text] [Related]
35. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Husson MO; Izard D; Leclerc H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
[TBL] [Abstract][Full Text] [Related]
36. Preclinical comparative evaluation of aminoglycosides.
Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
[TBL] [Abstract][Full Text] [Related]
37. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
[TBL] [Abstract][Full Text] [Related]
39. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]